Recurrence after resection of NSCLC

Surgical resection is the treatment of choice for early non-small cell lung cancer (NSCLC) and these patients have the best prognosis. However, local recurrence is a common cause of death in this group and the course and predictors of post-recurrence survival in resected stage I NSCLC have not been studied. In this month’s Thorax, Hung and colleagues studied local recurrence and its outlook in stage I NSCLC. The hazard of death was greater with large tumour size. Patients who were operated on again had the best outcome. These results are discussed …